NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/16/2022
Back to search
Official data from USPTO
TVAX BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/16/2022
Trademark type
Combined
Nice classes
44
Filing date
09/13/2011
Registration date
05/15/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
08/16/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/20/2010
First use in commerce
07/20/2010
Drawing code
3
Owner type
03
Owner location
OLATHE, KS, US
Examiner
WILLISTON, JENNIFER LYNN
Law office
L40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the word "TVAX" appearing above the word "BIOMEDICAL" within a rectangular box.
Holders and representatives
Holders
TVAX BIOMEDICAL, INC.
T. I. (pessoa física)
TVAX BIOMEDICAL, INC.
Representatives
Clinton G. Newton SHOOK, HARDY & BACON LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical serviceshuman cancer treatment involving the administration of activated patient T-cells
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/16/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/16/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/16/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
02/24/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/15/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/10/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/10/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/10/2017
E815
TEAS SECTION 8 & 15 RECEIVED
05/15/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/15/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/17/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/15/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2012
PUBO
PUBLISHED FOR OPPOSITION
02/28/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/26/2012
ALIE
ASSIGNED TO LIE
01/25/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
01/05/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/05/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
01/05/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/05/2012
DOCK
ASSIGNED TO EXAMINER
12/29/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
09/20/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/19/2011
NWAP
NEW APPLICATION ENTERED
09/16/2011
Continuous trademark protection
Get notified about every new filing that threatens TVAX BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.